ADVAIR HFA (GlaxoSmithKline LLC)


Welcome to the PulseAid listing for the ADVAIR HFA drug offered from GlaxoSmithKline LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline LLC
NON-PROPRIETARY NAME: fluticasone propionate and salmeterol xinafoate
SUBSTANCE NAME: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: AEROSOL, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-09-29
END MARKETING DATE: 0000-00-00


ADVAIR HFA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionADVAIR HFA from GlaxoSmithKline LLC
LABELER NAME: GlaxoSmithKline LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 45; 21(ug/1; ug/1)
START MARKETING DATE: 2008-09-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0173-0715_a30cf43f-52d4-4f4f-a325-eca8e7fc1425
PRODUCT NDC: 0173-0715
APPLICATION NUMBER: NDA021254

Other FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCADVAIR HFA
Teva Pharmaceuticals USA, Inc.Fluticasone Propionate and Salmeterol
Teva Respiratory, LLCAirDuo RespiClick